The effects of DPP-IV inhibition in NOD mice with overt diabetes

Folia Biologica (Czech Republic)

Volumn 59, Issue 3, 2013, Pages 116-122

  Vargova L ^a   Zacharovova K ^a   Dovolilova E ^a   Vojtova L ^a   Cimburek, Z ^b   Saudek, F ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

DPP IV; NOD mice; Regulatory T cells; Sitagliptin; Type 1 diabetes

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; SITAGLIPTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CD4 CD8 RATIO; CELL INFILTRATION; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FLOW CYTOMETRY; HYPERGLYCEMIA; IMMUNOCOMPETENT CELL; IMMUNOHISTOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPH NODE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; REGULATORY T LYMPHOCYTE; REMISSION; SPLEEN; T LYMPHOCYTE SUBPOPULATION; UPREGULATION;

MUS;

ANIMALS; DIABETES MELLITUS, TYPE 1; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DISEASE MODELS, ANIMAL; FEMALE; ISLETS OF LANGERHANS; LYMPH NODES; MICE; MICE, INBRED NOD; PYRAZINES; SPLEEN; T-LYMPHOCYTE SUBSETS; TIME FACTORS; TRIAZOLES;

EID: 84881101619     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Ablamunits, V., Sherry, N. A., Kushner, J. A., Herold, K. C. (2007) Autoimmunity and β cell regeneration in mouse and human type 1 diabetes: The peace is not enough. Ann. N. Y. Acad. Sci. 1103, 19-32.
2. Bosi, E. (2010) Time for testing incretin therapies in early type 1 diabetes? J. Clin. Endocrinol. Metab. 95, 2607-2609.
3. Ellis, S. L., Moser, E. G., Snell-Bergeon, J. K., Rodionova, A. S., Hazenfield, R. M., Garg, S. K. (2011) Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: A pilot, double-blind, randomized, crossover trial. Diabet. Med. 28, 1176-1181.
4. Hadjiyanni, I., Baggio, L. L., Poussier, P., Drucker, D. J. (2008) Exendin-4 modulates diabetes onset in nonobese diabetic mice. Endocrinology 149, 1338-1349.
5. Keenan, H. A., Sun, J. K., Levine, J., Doria, A., Aiello, L. P., Eisenbarth, G., Bonner-Weir, S., King, G. L. (2010) Residual insulin production and pancreatic b-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 59, 2846-2853.
6. Kielgast, U., Holst, J. J., Madsbad, S. (2011) Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual β-cell function. Diabetes 60, 1599-1607.
7. Kim, S. J., Nian, C., McIntosh, C. H. (2010) Sitagliptin (MK0431) inhibition of dipeptidyl peptidase IV decreases nonobese diabetic mouse CD4+ T-cell migration through incretin-dependent and -independent pathways. Diabetes 59, 1739-1750.
8. Kutoh, E. (2011) Sitagliptin is effective and safe as add-on to insulin in patients with absolute insulin deficiency: A case series. J. Med. Case Rep. 5, 117.
9. Mannucci, E., Pala, L., Ciani, S., Bardini, G., Pezzatini, A., Sposato, I., Cremasco, F., Ognibene, A., Rotella, C. M. (2005) Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus. Diabetologia 48, 1168-1172.
10. Mellanby, R. J., Thomas, D., Phillips, J. M., Cooke, A. (2007) Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells. Immunology 121, 15-28.
11. Ogawa, N., List, J. F., Habener, J. F., Maki, T. (2004) Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4. Diabetes 53, 1700-1705.
12. Roep, B. O., Peakman, M. (2012) Antigen targets of type 1 diabetes autoimmunity. Cold Spring Harb. Perspect. Med. 2, a007781.
13. Shoda, L. K., Young, D. L., Ramanujan, S., Whiting, C. C., Atkinson, M. A., Bluestone, J. A., Eisenbarth, G. S., Mathis, D., Rossini, A. A., Campbell, S. E., Kahn, R., Kreuwel, H. T. (2005) A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 23, 115-126.
14. Skowera, A., Ellis, R. J., Varela-Calvino, R., Arif, S., Huang, G. C., Van-Krinks, C., Zaremba, A., Rackham, C., Allen, J. S., Tree, T. I., Zhao, M., Dayan, C. M., Sewell, A. K., Unger, W. W., Drijfhout, J. W., Ossendorp, F., Roep, B. O., Peakman, M. (2008) CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J. Clin. Invest. 118, 3390-3402.
15. Suarez-Pinzon, W. L., Lakey, J. R., Rabinovitch, A. (2008) Combination therapy with glucagon-like peptide-1 and gastrin induces b-cell neogenesis from pancreatic duct cells in human islets transplanted in immunodeficient diabetic mice. Cell Transplant. 17, 631-640.
16. Suarez-Pinzon, W. L., Cembrowski, G. S., Rabinovitch, A. (2009) Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor restores normoglycaemia in non-obese diabetic mice. Diabetologia 52, 1680-1682.
17. Suen, C. S., Burn, P. (2012) The potential of incretin-based therapies in type 1 diabetes. Drug Discov. Today 17, 89-95.
18. Takeda, Y., Fujita, Y., Honjo, J., Yanagimachi, T., Sakagami, H., Takiyama, Y., Makino, Y., Abiko, A., Kieffer, T. J., Haneda, M. (2011) Reduction of both β cell death and α cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice. Diabetologia 55, 404-412.
19. Tian, B., Hao, J., Zhang, Y., Tian, L., Yi, H., O'Brien, T. D., Sutherland, D. E., Hering, B. J., Guo, Z. (2009) Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy. Transplantation 87, 198-206.
20. Tian, L., Gao, J., Hao, J., Zhang, Y., Yi, H., O'Brien, T. D., Sorenson, R., Luo, J., Guo, Z. (2010) Reversal of new-onset diabetes through modulating inflammation and stimulating β-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor. Endocrinology 151, 3049-3060.
21. Xue, S., Wasserfall, C. H., Parker, M., Brusko, T. M., McGrail, S., McGrail, K., Moore, M., Campbell-Thompson, M., Schatz, D. A., Atkinson, M. A., Haller, M. J. (2008) Exendin-4 therapy in NOD mice with new-onset diabetes increases regulatory T cell frequency. Ann. N. Y. Acad. Sci. 1150, 152-156.
22. Zhang, J., Tokui, Y., Yamagata, K., Kozawa, J., Sayama, K., Iwahashi, H., Okita, K., Miuchi, M., Konya, H., Hamaguchi, T., Namba, M., Shimomura, I., Miyagawa, J. I. (2007) Continuous stimulation of human glucagon-like peptide-1 (7-36) amide in a mouse model (NOD) delays onset of autoimmune type 1 diabetes. Diabetologia 50, 1900-1909.